(MedPage Today) — SAN FRANCISCO — Prophylactic whole-pelvic radiation therapy (RT) did not perform as expected for patients with unfavorable intermediate-risk or favorable high-risk prostate cancer, according to interim results from a large…

Read the full article on medpagetoday.com